Controversy on the treatment of multiple sclerosis and related disorders: positional statement of the expert panel in charge of the 2021 DGN Guideline on diagnosis and treatment of multiple sclerosis, neuromyelitis optica spectrum diseases and MOG-IgG-associated disorders
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-08-01
|
Series: | Neurological Research and Practice |
Online Access: | https://doi.org/10.1186/s42466-021-00139-8 |
id |
doaj-b9c037afeb504331a889aa53da9d70aa |
---|---|
record_format |
Article |
spelling |
doaj-b9c037afeb504331a889aa53da9d70aa2021-08-08T11:06:53ZengBMCNeurological Research and Practice2524-34892021-08-01311710.1186/s42466-021-00139-8Controversy on the treatment of multiple sclerosis and related disorders: positional statement of the expert panel in charge of the 2021 DGN Guideline on diagnosis and treatment of multiple sclerosis, neuromyelitis optica spectrum diseases and MOG-IgG-associated disordersA. Bayas0A. Berthele1B. Hemmer2C. Warnke3B. Wildemann4Universitätsklinikum Augsburg, Klinik für Neurologie und klinische NeurophysiologieTechnische Universität München, Fakultät für Medizin, Klinikum rechts der Isar, Klinik für NeurologieTechnische Universität München, Fakultät für Medizin, Klinikum rechts der Isar, Klinik für NeurologieKlinik und Poliklinik für Neurologie, Medizinische Fakultät, Universitätsklinik KölnNeurologische Klinik, Universitätsklinikum Heidelberghttps://doi.org/10.1186/s42466-021-00139-8 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
A. Bayas A. Berthele B. Hemmer C. Warnke B. Wildemann |
spellingShingle |
A. Bayas A. Berthele B. Hemmer C. Warnke B. Wildemann Controversy on the treatment of multiple sclerosis and related disorders: positional statement of the expert panel in charge of the 2021 DGN Guideline on diagnosis and treatment of multiple sclerosis, neuromyelitis optica spectrum diseases and MOG-IgG-associated disorders Neurological Research and Practice |
author_facet |
A. Bayas A. Berthele B. Hemmer C. Warnke B. Wildemann |
author_sort |
A. Bayas |
title |
Controversy on the treatment of multiple sclerosis and related disorders: positional statement of the expert panel in charge of the 2021 DGN Guideline on diagnosis and treatment of multiple sclerosis, neuromyelitis optica spectrum diseases and MOG-IgG-associated disorders |
title_short |
Controversy on the treatment of multiple sclerosis and related disorders: positional statement of the expert panel in charge of the 2021 DGN Guideline on diagnosis and treatment of multiple sclerosis, neuromyelitis optica spectrum diseases and MOG-IgG-associated disorders |
title_full |
Controversy on the treatment of multiple sclerosis and related disorders: positional statement of the expert panel in charge of the 2021 DGN Guideline on diagnosis and treatment of multiple sclerosis, neuromyelitis optica spectrum diseases and MOG-IgG-associated disorders |
title_fullStr |
Controversy on the treatment of multiple sclerosis and related disorders: positional statement of the expert panel in charge of the 2021 DGN Guideline on diagnosis and treatment of multiple sclerosis, neuromyelitis optica spectrum diseases and MOG-IgG-associated disorders |
title_full_unstemmed |
Controversy on the treatment of multiple sclerosis and related disorders: positional statement of the expert panel in charge of the 2021 DGN Guideline on diagnosis and treatment of multiple sclerosis, neuromyelitis optica spectrum diseases and MOG-IgG-associated disorders |
title_sort |
controversy on the treatment of multiple sclerosis and related disorders: positional statement of the expert panel in charge of the 2021 dgn guideline on diagnosis and treatment of multiple sclerosis, neuromyelitis optica spectrum diseases and mog-igg-associated disorders |
publisher |
BMC |
series |
Neurological Research and Practice |
issn |
2524-3489 |
publishDate |
2021-08-01 |
url |
https://doi.org/10.1186/s42466-021-00139-8 |
work_keys_str_mv |
AT abayas controversyonthetreatmentofmultiplesclerosisandrelateddisorderspositionalstatementoftheexpertpanelinchargeofthe2021dgnguidelineondiagnosisandtreatmentofmultiplesclerosisneuromyelitisopticaspectrumdiseasesandmogiggassociateddisorders AT aberthele controversyonthetreatmentofmultiplesclerosisandrelateddisorderspositionalstatementoftheexpertpanelinchargeofthe2021dgnguidelineondiagnosisandtreatmentofmultiplesclerosisneuromyelitisopticaspectrumdiseasesandmogiggassociateddisorders AT bhemmer controversyonthetreatmentofmultiplesclerosisandrelateddisorderspositionalstatementoftheexpertpanelinchargeofthe2021dgnguidelineondiagnosisandtreatmentofmultiplesclerosisneuromyelitisopticaspectrumdiseasesandmogiggassociateddisorders AT cwarnke controversyonthetreatmentofmultiplesclerosisandrelateddisorderspositionalstatementoftheexpertpanelinchargeofthe2021dgnguidelineondiagnosisandtreatmentofmultiplesclerosisneuromyelitisopticaspectrumdiseasesandmogiggassociateddisorders AT bwildemann controversyonthetreatmentofmultiplesclerosisandrelateddisorderspositionalstatementoftheexpertpanelinchargeofthe2021dgnguidelineondiagnosisandtreatmentofmultiplesclerosisneuromyelitisopticaspectrumdiseasesandmogiggassociateddisorders |
_version_ |
1721216313019334656 |